Immediate Impact
2 from Science/Nature 53 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Targeting immunogenic cell stress and death for cancer therapy
2024 Standout
Works of Rouven Müller being referenced
Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial
2018
inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rouven Müller | 117 | 75 | 174 | 184 | 19 | 422 | |
| Jesper Haaning | 143 | 118 | 107 | 106 | 16 | 484 | |
| B. Nagy | 73 | 79 | 254 | 207 | 17 | 445 | |
| T. Somville | 125 | 26 | 163 | 88 | 29 | 385 | |
| A. Abbas | 64 | 47 | 169 | 286 | 24 | 470 | |
| C. M. Towler | 52 | 107 | 120 | 97 | 17 | 431 | |
| Hanna G. Kaspar | 70 | 43 | 141 | 77 | 25 | 427 | |
| Valerie J. Rappaport | 52 | 20 | 226 | 154 | 19 | 471 | |
| Motoki Bonno | 44 | 49 | 61 | 132 | 28 | 474 | |
| S Pildner von Steinburg | 30 | 36 | 111 | 204 | 26 | 419 | |
| Ercüment Müngen | 39 | 13 | 228 | 167 | 32 | 407 |
All Works
Loading papers...